Virtual women’s healthcare platform Allara Health scored $26 million in Series B funding, bringing its total raise to $38.5 million. Index Ventures led the round with participation from existing investor GV (Google Ventures).
WHAT IT DOES
Allara…
In a complex, multimodal imaging environment, with radiology and other images and reports scattered across any number of PACS systems and electronic health records, clinical and technology leaders at Cleveland-based MetroHealth had one “guiding…
Continue Reading
Differentiating between diabetic nephropathy (DN) and non-diabetic renal disease (NDRD) without a kidney biopsy remains a major challenge, often leading to missed opportunities for targeted treatments that could greatly improve NDRD outcomes. To reform…
Continue Reading
Atropos Health, a company translating real-world clinical data into real-world evidence (RWE) for decision making, is partnering with xCures, an AI-powered healthcare data retrieval company, to harness RWE-based insights to support patient care.The aim…
Continue Reading
In this interview, Dr. Samir Shah, Chief Medical Officer at Qure.ai, shares why achieving FDA approval is crucial for their AI solutions and for fostering trust in the technology. Dr. Shah discusses how their…
Continue Reading
What You Should Know:
– HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry.
– GAMEFILM Registry…
Continue Reading
As artificial intelligence evolves and advances the ways in which clinicians care for patients, there will be new impacts on outpatient radiology technology.Already, AI in outpatient radiology enhances radiology screenings by boosting the detection…
Continue Reading
GE HealthCare Technologies Inc. and the University of California San Francisco and its Department of Radiology and Biomedical Imaging have formed a new partnership to collaborate on advanced imaging and precision oncology, the company…
Continue Reading
Revolutionary Phase III Trial Results
Bayer has announced groundbreaking topline results from their Phase III QUANTI studies evaluating gadoquatrane, an innovative gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI). The revolutionary aspect of this…
What You Should Know:
– Core Sound Imaging, the company behind the innovative medical imaging platform Studycast, today announced a $80M growth investment from PSG, a growth equity firm.
– The funding will accelerate Studycast’s mission…
Continue Reading
